| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |